AGC Biologics Expands Capacity

Adds 2000L SUB at Berkeley, CA facility

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AGC Biologics, a clinical and commercial manufacturer of therapeutic proteins, is expanding capacity at its Berkeley, CA facility with the addition of a 2000L single-use bioreactor (SUB). With this new 2000L SUB, the Berkeley facility has tripled capacity over the last three years, and now offers cell culture manufacturing in scales from 100L to 3000L, with both SUBs and stainless steel bioreactors. In addition to cGMP manufacturing, the facility provides cell bank manufacturing and storage. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters